Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sandoz

Sandoz
1886 FOUNDED
M&A STATUS
20K-25K EMPLOYEES
Merger of Eq. LATEST DEAL TYPE
1 FINANCING ROUNDS
9 INVESTMENTS
Description

Manufacturer of generic pharmaceutical products. The company produces oncology and biotechnological products as well as therapeutic medicines.

Website
Formerly Known As
Chemical Company Kern & Sandoz
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • Industriestrasse 25
  • 83607 Holzkirchen
  • Germany

+49 08024 0000

Sandoz Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sandoz‘s full profile, request access.

Request full access to PitchBook

Sandoz Competitors (44)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Upsher-Smith Laboratories Corporate Backed or Acquired Maple Grove, MN 000000&0
0000000 0000000000 Corporation Dhaka, Bangladesh 0000
0000000 0000000 Formerly PE-Backed Philadelphia, PA 0000 00000 000000000 00000
00000000 Corporate Backed or Acquired Dublin, Ireland 00000 000000&0
000 0000000 0000 0 Formerly PE-Backed Livonia, MI 000 000.00 000000&0 000.00
To view this company’s complete list of competitors, request access »

Sandoz Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000-00000 00000 15-Dec-2016 000000000 00000 00 Pharmaceuticals
000000 (0000000000 12-Feb-2016 000000000 00000 00 Biotechnology 0000000 0000000
0000000 0000000000 23-Jul-2012 000000000000000000 00.000 Pharmaceuticals
00000 000000000000 01-Apr-2010 000000000000000000 00000 Therapeutic Devices
Sandoz Canada 16-Aug-2004 Merger/Acquisition 00000 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Sandoz Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0-0000 31-Oct-2000 00000 00000 00 0000 Completed
  • 000000
Nabriva Therapeutics Corporate Completed
To view this company’s complete exits history, request access »

Sandoz Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000 Biotechnology Gaithersburg, MD 0000
To view this company’s complete subsidiary history, request access »

Sandoz Executive Team (9)

Name Title Board
Seat
Contact
Info
Francesco Balestrieri Interim Chief Executive Officer & Head, Europe
Philippe Deecke Chief Financial Officer
Arnaud Vincent Chief Financial Officer, France
Hitesh Bhansari Strategy and Operations Lead, US and LatAm
Pierluigi Antonelli Head of Western Europe

4 Former Executives

You’re viewing 5 of 9 executives. Get the full list »